Quadrature Capital LTD Meridian Bioscience Inc Transaction History

Quadrature Capital LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $271,248 - $361,931	-11,421 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $228,077 - $307,681	11,421 New	11,421 $297,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $235,174 - $369,802	-13,058 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $258,026 - $390,303	13,058 New	13,058 $343,000
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $92,378 - $190,727	-16,585 Closed	0 $0
Q4 2019 Aug 26, 2020	BUY	$7.9 - $10.14 $131,021 - $168,171	16,585 New	16,585 $162,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $147,698 - $189,577	-18,696 Closed	0 $0
Q3 2019 Aug 26, 2020	SELL	$9.17 - $12.01 $86,106 - $112,773	-9,390 Reduced 33.43%	18,696 $177,000
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $136,348 - $220,563	12,532 Added 80.57%	28,086 $0
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $225,844 - $306,724	15,554 New	15,554 $270,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.